Chronic and Acute Asthma: Pathophysiology, Age, and Treatment
This paper examines the pathophysiology of chronic asthma and acute asthma exacerbation, comparing their cellular mechanisms, airway responses, and effects on arterial blood gas. It discusses how aging alters respiratory and immune physiology in ways that complicate both diagnosis and disease progression. Diagnostic tools — including chest X-ray, arterial blood gas testing, pulmonary function testing, and pulse oximetry — are reviewed in the context of age-appropriate assessment. The paper concludes by noting that, while no cure exists, targeted pharmacological management remains the standard of care for controlling asthma symptoms across all age groups.
- Pathophysiology of Chronic Asthma: Cellular mechanisms, airway inflammation, and blood gas effects
- Pathophysiology of Acute Asthma Exacerbation: Immune cells, bronchospasm, and respiratory acidosis in exacerbation
- Impact of Age on Asthma Progression: How aging masks asthma symptoms and alters pathophysiology
- Diagnosis Across Age Groups: Diagnostic tools including blood gas testing and spirometry
- Treatment and Disease Management: Medication and inhaler-based approaches to asthma control
- References: APA-formatted source citations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly distinguishes the cellular mechanisms of chronic asthma from those of acute exacerbation, helping readers understand each condition on its own terms before comparing them.
- Integrates the impact of patient age throughout, showing how physiological changes in older adults complicate both the recognition and pathophysiology of asthma.
- Grounds clinical claims in specific diagnostic tools (arterial blood gas, pulse oximetry, pulmonary function testing), making abstract pathophysiology concrete and clinically relevant.
Key academic technique demonstrated
The paper applies a compare-and-contrast structure at the cellular level, systematically tracing how similar inflammatory mechanisms produce different clinical presentations in chronic versus acute asthma. This technique allows the author to highlight the role of individual cell types — mast cells, eosinophils, neutrophils — without losing the larger clinical picture.
Structure breakdown
The paper opens with the pathophysiology of chronic asthma, then transitions to acute exacerbation, drawing explicit parallels and distinctions. A dedicated section on age follows, addressing how physiological aging masks asthma progression. The paper then covers diagnostic strategies, briefly treats management options, and closes with a reference list formatted in APA style. Total length is concise, appropriate for an undergraduate health sciences paper.
Pathophysiology of Chronic Asthma
Chronic asthma is a chronic inflammatory disorder of the bronchial mucosa that results in constriction of the airways, bronchial hyper-responsiveness, and variable — yet reversible — airflow obstruction. At the cellular level, chronic asthma is characterized by an increase in mucus secretion and bronchoconstriction stimuli. The condition can damage the epithelial cells found in the lungs, which accelerates recurrence and leads to more severe episodes. During an inflammatory response, toxic neuropeptides and eosinophils are released, causing direct tissue damage and potentially increasing bronchial hyper-responsiveness (Huether & McCance, 2012).
Oxygenation is normally compromised due to restriction of the bronchial airway in chronic asthma. In particular, the arterial blood gas is affected in patients by hyperventilation, which induces hypoxemia and results in respiratory alkalosis (Gelb & Nadel, 2015).
Pathophysiology of Acute Asthma Exacerbation
The pathophysiological mechanism of acute asthma exacerbation is similar to that of chronic asthma in that the bronchial airways are compromised, creating resistance to airflow. However, a broader range of cell types contributes to airway hypersensitivity during an acute exacerbation. These include T helper 2 lymphocytes, dendritic cells, B lymphocytes, neutrophils, basophils, eosinophils, and mast cells. During an acute exacerbation, these cells react with a latent release of inflammatory mediators that causes bronchospasm, edema, and increased secretions.
Acute asthma exacerbation tends to be more severe than chronic asthma attacks, largely because patients experience a delayed inflammatory cell response. These exacerbations also affect arterial blood gas, as is the case with chronic asthma. Patients suffering from acute exacerbation exhibit short inspirations and prolonged expirations, which impairs oxygenation. They tend to trap air, creating a respiratory disadvantage that leads to decreased tidal volume, increased carbon dioxide retention, and ultimately respiratory acidosis.
Impact of Age on Asthma Progression
While asthma affects both children and adults, it is most prevalent in children, affecting approximately 10 percent of those under 17 years of age in the United States. Asthma in aging adults is not easily recognized because other age-related changes occur in respiratory and immune physiology that mask disease progression until it becomes severe. Physiological changes within the organs, cells, and tissues of older adults result in diminished functional reserve, thereby increasing susceptibility to the disease (Hanania et al., 2011).
While the condition is generally easier to diagnose in children, diagnosis becomes considerably more challenging in older adults. There is increasingly small airway involvement, heightened neutrophilic inflammation, and decreased eosinophil function in older adults (Dunn et al., 2015), all of which alter the pathophysiology of chronic asthma in this population.
Create your account
Always verify citation format against your institution’s current style guide requirements.